About Biorasi
Biorasi is a company based in Miami (United States) founded in 2002 was acquired by RLH in November 2018. The company has 104 employees as of December 31, 2022. Biorasi offers products and services including Phase Ib-III Trials, Patient Engagement and Recruitment, and Decentralized and Virtual Solutions. Biorasi operates in a competitive market with competitors including Celgene, Medelis WCCT Global, Syneos Health, Emmes and Parexel, among others.
- Headquarter Miami, United States
- Employees 104 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
104
as on Dec 31, 2022
-
Acquired by
RLH
(Nov 16, 2018)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Biorasi
Biorasi offers a comprehensive portfolio of products and services, including Phase Ib-III Trials, Patient Engagement and Recruitment, and Decentralized and Virtual Solutions.
Conducts phases of clinical trials for drug and device testing.
Optimizes strategies for faster patient enrollment in trials.
Enables remote monitoring and virtual conduct of clinical studies.
People of Biorasi
Unlock access to complete
Unlock access to complete
Funding Insights of Biorasi
Detailed funding history for Biorasi
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Biorasi
Biorasi has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include RLH Equity Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity investments are made in tech-enabled service firms.
|
Locked | Locked | Locked |
Investor details for Biorasi
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Biorasi
Investment portfolio details for Biorasi
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Biorasi
Detailed financials for Biorasi
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Biorasi Comparisons
Peer comparison for Biorasi
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Biorasi
Biorasi operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Celgene, Medelis WCCT Global, Syneos Health, Emmes and Parexel, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Therapies for cancer and inflammatory diseases are developed.
|
|
| Locked | Locked | Locked |
Full-service CRO expertise in influenza and oncology research is offered.
|
|
| Locked | Locked | Locked |
CRO clinical development services are provided by Syneos Health.
|
|
| Locked | Locked | Locked |
Outsourced contract research organization services are provided to clients.
|
|
| Locked | Locked | Locked |
Full-service clinical research organization services are provided globally by Parexel.
|
|
| Locked | Locked | Locked |
Global full-service CRO services are delivered in over 80 countries.
|
Detailed competitors of Biorasi
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Biorasi
Complete news archive for Biorasi
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Biorasi
Biorasi was founded in 2002.
Biorasi is headquartered in Miami, United States. It is registered at Miami, Florida, United States.
As of Dec 31, 2022, the latest employee count at Biorasi is 104.
The company was founded in 2002 and is headquartered in Miami, United States, with global operations in the clinical research sector. Full-service contract research organization (CRO) capabilities are offered, including management of biosimilar trials and study rescue services. Expertise covers therapeutic areas such as nephrology, neurology, womens health, autoimmune diseases, immunology, and oncology. A proprietary platform named TALOS is utilized for trial optimization and proactive issue identification.
Biorasi's top competitors include Emmes, Syneos Health and ClinChoice.
Biorasi offers Phase Ib-III Trials, Patient Engagement and Recruitment, and Decentralized and Virtual Solutions.
Biorasi has 1 investor. Key investors include RLH Equity Partners.